Skip to content
NOTICIAS
PUBLICACIONES
- HIV enters the brain and doesn’t leave – paradoxically, drugs intended to reduce brain inflammation increase virus levels
- From viral drift to tumor drift: why cancer immunotherapy needs B cells and dynamic adaptation
- VSIG4 suppresses antitumor T cell immunity via the SLC3A2-dependent metabolic-ionic checkpoint
- USP1-mediated lipophagy-lipogenesis axis drives cholangiocarcinoma progression and immune evasion
- CD70-targeted platform for diagnosing and treating multiple myeloma
- Targeting ATF4 overcomes dual resistance to chemo-immunotherapy in gastric cancer by disrupting the DNA damage response
- First-in-human, phase 1, open-label study of alomfilimab, an anti-ICOS antibody, as a single agent and in combination with anti-PD-L1 in advanced malignancies
- Extrafollicular plasma cells suppress T cell priming in tumour-draining lymph nodes
- IFITM1 differentially regulates antibacterial immunity and immunopathology but is dispensable for antiparasitic responses
- Adjuvants orchestrate cross-organ induction of mucosal CD8+ T cell immune responses in respiratory tracts
- Fate mapping reveals a prenatal-to-neonatal wave of ILC2s with a history of Cd3g expression
- Dementia risk linked to nitrate in drinking water, study finds
- First-line serplulimab plus chemotherapy versus chemotherapy alone in small-cell lung cancer patients with brain metastases: a multicenter, prospective cohort study
- Glycolytic reprogramming in cancer: immune crosstalk, nutrient competition, and supportive care perspectives
- Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review
- Telitacicept in refractory juvenile generalized myasthenia gravis: a case report and collective analysis
- Pharmacological ZO-1 agonist treatment attenuates ammonia nitrogen stress-induced mucosal inflammation and intestinal barrier failure in Leiocassis longirostris
- Tagraxofusp in adult blastic plasmacytoid dendritic cell neoplasm: clinical trials and real-world outcomes: a systematic review
- Multi-omics analysis of kidney renal cell carcinoma in silico with preliminary in vivo validation
- Rearming mesenchymal stem cells with engineering strategies to combat cancer
- Plasma gamma-glutamylglycine predicts the seroconversion of hepatitis B e antigen in patients with chronic hepatitis B
- Plasma cell mastitis: a comprehensive review of etiological advances and future directions
- Electroacupuncture at LI11 and SP10 is associated with alleviation of acute urticaria-like reactions in passive cutaneous anaphylaxis: an exploratory analysis of complement-related proteins and multiscale omics
- Polysaccharides-gut microbiota interaction: mechanisms regulating the hepatocellular carcinoma immune microenvironment
- Tislelizumab combined with gemcitabine as first-line treatment in cisplatin-ineligible patients with locally advanced or metastatic urothelial carcinoma: a single center, single-arm phase 2 trial
- The gut-joint axis in gout: microbial outer membrane vesicles and m6A-mediated metabolic-epigenetic coupling from acute flare to chronicity
- Case Report: early regression and bladder-intact survival after limited-course immunotherapy-based systemic therapy in two patients with clinically staged bulky muscle-invasive bladder cancer
- TIFA: a signaling hub linking inflammation, innate immunity, and human disease
- Restoration of melatonin rhythms reduces tumour-promoting inflammation in oesophageal cancer survivors: a prospective cohort study
- FGF7 mitigates airway inflammation and epithelial injury in cigarette smoke-induced COPD model
- Evaluation of a strain Long human respiratory syncytial virus with M2–2 gene deletion in intranasally vaccinated BALB/c mice
- From thresholds to trajectories: a perspective on reframing alloimmune risk for computational modeling in solid organ transplantation
